Abstract
Hypercholesterolaemia has not been part of our clinical vocabulary for several decades, so why has hypertension not gone the same way? The latest individual participant-level data meta-analysis from the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)1 is yet another nail in the coffin for hypertension. The new study included 51 trials, with 358 707 participants (149 211 [41·6%] women and 209 496 [58·4%] men) aged 21–105 years, who had 42 947 major cardiovascular events during approximately 4 years of follow-up.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
